ログイン

Introduction to Leukemia Part 2

Introduction to Leukemia Part 2
68問 • 2年前
  • MAHATHIR ALPHA
  • 通報

    問題一覧

  • 1

    - Acute megakaryoblastic leukemia - This is a rare disorder characterized by extensive proliferation of megakaryoblasts, atypical megakaryocytes and thrombocytopenia

    M7

  • 2

    What are the 2 goals in the treatment if Leukemias

    Eradicate the leukemic cell mass, Give supportive care

  • 3

    What are the four general types of theraphy for leukemias?

    Chemotherapy, Bone marrow transplant, Radiotheraphy, Immunotheraphy, Monoclonal antibodies

  • 4

    A combination of drugs is usually used in this theraphy

    Chemotheraphy

  • 5

    It stimulate the patients own immune system to mount a response against the malignant cells

    Immunotheraphy

  • 6

    An example of these are Rituxin

    Monoclonal antibodies

  • 7

    Fill in the Blanks: Blast cut-off for a diagnosis of AML WHO- ____ FAB- ____

    20%, 30%

  • 8

    AML with blasts 20 - 30 % by WHO can benefit from therapies for ________________ that were approved by USFDA

    MYELODYSPASIA

  • 9

    Small, monomorphic

    L1

  • 10

    Large, heterogenous

    L2

  • 11

    Burkitt-cell type

    L3

  • 12

    Minimally differentiated

    M0

  • 13

    Without maturation

    M1

  • 14

    With maturation

    M2

  • 15

    Hypergranular promyelocytic

    M3

  • 16

    Myelomonocytic

    M4

  • 17

    (a) monoblastic, (b) monocytic

    M5

  • 18

    Erythroleukemia

    M6

  • 19

    Megakaryoblastic

    M7

  • 20

    Undifferentiated blasts, AML-not otherwise categorized

    M0 myeloid

  • 21

    Blasts and promyelocytes predominate without further maturation of myeloid cells

    M1 myeloid

  • 22

    Myeloid cells demonstrate maturation beyond the blast and promyelocyte stage

    M2 myeloid

  • 23

    Promyelocytes predominate in the bone marrow

    M3 myelomonocyte

  • 24

    Both myeloid and monocytic cells are present to the extent of at least 20% of the total leukocytes

    M4 myelomonoctyic

  • 25

    Most cells are monocytic; two subtypes (a and b) are recognized, one characterized by large blasts in bone marrow and peripheral blood, the other (differentiated type) by monoblasts, promonocytes, and monocytes

    M5 monocytic

  • 26

    Also known as Di Guglielmo syndrome; abnormal proliferation of both erythroid and granulocytic precursors; may include abnormal megakaryocytic and monocytic proliferations

    M6 erythroleukemia

  • 27

    Large and small megakaryoblasts with a high nuclear- cytoplasmic ratio; pale, agranular cytoplasm

    M7 megakaryocytic

  • 28

    One population of cells within the case; small cells predominant; nuclear shape is regular with an occasional cleft; chromatin pattern is homogeneous and nucleoli are rarely visible; cytoplasm is moderately basophilic

    L1 homogenous

  • 29

    Large cells with an irregular nuclear shape; clefts in the nucleus are common; one or more large nucleoli are visible; cytoplasm varies in color

    L2 heterogenous

  • 30

    Cells are large and homogeneous in size; nuclear shape is round or oval; one to three prominent nucleoli; cytoplasm is deeply basophilic with vacuoles often prominent

    L3 Burkitt lymphoma type

  • 31

    Try to familliarize!

    .

  • 32

    Try to familliarize!

    .

  • 33

    Try to familliarize!

    .

  • 34

    Try to familliarize!

    .

  • 35

    Try to familliarize!

    .

  • 36

    Try to familliarize!

    .

  • 37

    There is an increase in both erythroblasts and myeloblasts

    Erythroleukemia

  • 38

    They may possibly cause myeloblastic leukemia

    M1, M2 or M4

  • 39

    3 sequentially morphological defined phases

    Preponderance of abnormal erythroblasts, Erythroleukemia, Myeloblastic leukemia

  • 40

    Erythroleukemia

    M6

  • 41

    -This is rare and is characterized by a bone marrow having a predominance of erythroblast -It has three sequentially morphologically defined phases -Anemia is common

    M6

  • 42

    -Acute monoblastic leukemia - >80% of the nonerythroid cells in the bone marrow are monocytic -There is extensive infiltration of the gums, CNS, lymph nodes and extramedullary sites

    M5

  • 43

    This type of M5 is well differentiated (<80% monoblasts)

    M5B

  • 44

    This type of M5 is poorly differentiated (>80% monoblasts)

    M5A

  • 45

    M5 is further divided into:

    M5A, M5B

  • 46

    -Acute myelomonoblastic leukemia -Both myeloblasts and monoblasts are seen in the bone marrow and peripheral blood -Infiltration of extramedullary sites is more common than with the pure granulocytic variants

    M4

  • 47

    -Hypogranular promyelocytic -The bone marrow has > 30% blasts -The WBC count is increased. -Like the M3 type, treatment causes a release of the granules and may send the patient into disseminated intravascular coagulation and subsequent bleeding and -It is characterized by a 15,17 translocation

    M3m

  • 48

    M3m is characterized by what?

    15,17 chromosomal translocation

  • 49

    M3 is characterized by what?

    15,17 chromosomal translocation

  • 50

    M2 is characterized by what?

    8,21 chromosomal translocation

  • 51

    What does the treatment of M3 causes?

    Treatment causes a release of the granules and may send the patient into disseminated intravascular coagulation and subsequent bleeding

  • 52

    -Hypergranular promyelocytic -This form of AML has a bone marrow with >30% blasts -Is more virulent than other forms -Occurs with a medium age of 39 -The WBC count is decreased -Treatment causes a release of the granules and may send the patient into disseminated intravascular coagulation and subsequent bleeding -It is characterized by a 15,17 chromosomal translocation

    M3

  • 53

    -Myeloblastic with maturation -The bone marrow shows 30-89% blasts and > 10% promyelocytes; -This is characterized by an 8,21 chromosomal translocation -This occurs in older adults

    M2

  • 54

    - Myeloblastic without maturation - The bone marrow shows >90% blasts and < 10% promyelocytes -The disease occurs in older adults

    M1

  • 55

    What are the different classifications of Acute myeloid leukemia ?

    M1, M2, M3, M3m, M4, M5, M6, M7

  • 56

    The classification of Acute myeloid leukemia depends on this factors

    Bone marrow blast morphology, Degree of cell maturation, Cytochemical stains, Immunophenotyping

  • 57

    What is the other term for Acute myeloid leukemia?

    Acute granulocyte leukemia

  • 58

    It is a rare trilineage leukemia

    B/T lymphoid/myeloid

  • 59

    Acute leukemias with mixed lineage(binotypic/phenotypes for two different lineages)

    B lymphoid/myeloid, T lymphoid/myeloid, B/T lymphoid, Myeloid/Natural killer, B/T lymphoid/myeloid

  • 60

    •It is more common in males •It has a poorer prognosis than any of the B cell ALLs which have a cure rate of 70%

    T cell ALL

  • 61

    True/False: If the WBC count is < 10 x 109/L at presentation, the prognosis is good; If the WBC count is > 20 x 109/L at presentation the prognosis is poor.

    True

  • 62

    Patients younger then 1 and greater than 13 have a _______________.

    poor prognosis

  • 63

    What are the most important prognostic indicators?

    Age, WBC counts, Cell type

  • 64

    Clinical findings of ALL

    Pancytopenia with resulting fatigue, pallor, fever, weight loss, irritability, anorexia, infection, bleeding, and bone pain.

  • 65

    Where does L2 occurs?

    In adults

  • 66

    Absence of any leukemia related signs and symptoms and return of bone marrow and peripheral blood values to within normal value

    Complete remission

  • 67

    Infiltration of extramedullary sites are common

    M4

  • 68

    Extensive infiltration of the gums, CNS....

    M5

  • Translation(Pre-finals)

    Translation(Pre-finals)

    MAHATHIR ALPHA · 55問 · 2年前

    Translation(Pre-finals)

    Translation(Pre-finals)

    55問 • 2年前
    MAHATHIR ALPHA

    Moving Test(Pre-finals)

    Moving Test(Pre-finals)

    MAHATHIR ALPHA · 75問 · 2年前

    Moving Test(Pre-finals)

    Moving Test(Pre-finals)

    75問 • 2年前
    MAHATHIR ALPHA

    Sporozoa(Prefinals)

    Sporozoa(Prefinals)

    MAHATHIR ALPHA · 80問 · 2年前

    Sporozoa(Prefinals)

    Sporozoa(Prefinals)

    80問 • 2年前
    MAHATHIR ALPHA

    Transcription

    Transcription

    MAHATHIR ALPHA · 46問 · 2年前

    Transcription

    Transcription

    46問 • 2年前
    MAHATHIR ALPHA

    GE Elective 2 Prefinal

    GE Elective 2 Prefinal

    MAHATHIR ALPHA · 15問 · 2年前

    GE Elective 2 Prefinal

    GE Elective 2 Prefinal

    15問 • 2年前
    MAHATHIR ALPHA

    Extra info for Malaria(Pre mid)

    Extra info for Malaria(Pre mid)

    MAHATHIR ALPHA · 25問 · 2年前

    Extra info for Malaria(Pre mid)

    Extra info for Malaria(Pre mid)

    25問 • 2年前
    MAHATHIR ALPHA

    NEMATODES(QUIZ)

    NEMATODES(QUIZ)

    MAHATHIR ALPHA · 45問 · 2年前

    NEMATODES(QUIZ)

    NEMATODES(QUIZ)

    45問 • 2年前
    MAHATHIR ALPHA

    PARA FINALS QUIZ 2

    PARA FINALS QUIZ 2

    MAHATHIR ALPHA · 51問 · 2年前

    PARA FINALS QUIZ 2

    PARA FINALS QUIZ 2

    51問 • 2年前
    MAHATHIR ALPHA

    MUTATION CYTOGENETICS

    MUTATION CYTOGENETICS

    MAHATHIR ALPHA · 42問 · 2年前

    MUTATION CYTOGENETICS

    MUTATION CYTOGENETICS

    42問 • 2年前
    MAHATHIR ALPHA

    AUBF PRE- FINAL 1ST QUIZ

    AUBF PRE- FINAL 1ST QUIZ

    MAHATHIR ALPHA · 51問 · 2年前

    AUBF PRE- FINAL 1ST QUIZ

    AUBF PRE- FINAL 1ST QUIZ

    51問 • 2年前
    MAHATHIR ALPHA

    Haemocytometry

    Haemocytometry

    MAHATHIR ALPHA · 20問 · 2年前

    Haemocytometry

    Haemocytometry

    20問 • 2年前
    MAHATHIR ALPHA

    Introduction to Microbiology

    Introduction to Microbiology

    MAHATHIR ALPHA · 46問 · 2年前

    Introduction to Microbiology

    Introduction to Microbiology

    46問 • 2年前
    MAHATHIR ALPHA

    History of Microbiology

    History of Microbiology

    MAHATHIR ALPHA · 100問 · 2年前

    History of Microbiology

    History of Microbiology

    100問 • 2年前
    MAHATHIR ALPHA

    History of Microbiology Part II

    History of Microbiology Part II

    MAHATHIR ALPHA · 9問 · 2年前

    History of Microbiology Part II

    History of Microbiology Part II

    9問 • 2年前
    MAHATHIR ALPHA

    Hematopoesis

    Hematopoesis

    MAHATHIR ALPHA · 39問 · 2年前

    Hematopoesis

    Hematopoesis

    39問 • 2年前
    MAHATHIR ALPHA

    Bacterial Taxonomy

    Bacterial Taxonomy

    MAHATHIR ALPHA · 18問 · 2年前

    Bacterial Taxonomy

    Bacterial Taxonomy

    18問 • 2年前
    MAHATHIR ALPHA

    Comparison of Prokaryotic and Eukaryotic Cell Structure

    Comparison of Prokaryotic and Eukaryotic Cell Structure

    MAHATHIR ALPHA · 23問 · 2年前

    Comparison of Prokaryotic and Eukaryotic Cell Structure

    Comparison of Prokaryotic and Eukaryotic Cell Structure

    23問 • 2年前
    MAHATHIR ALPHA

    Bacterial Morphology

    Bacterial Morphology

    MAHATHIR ALPHA · 19問 · 2年前

    Bacterial Morphology

    Bacterial Morphology

    19問 • 2年前
    MAHATHIR ALPHA

    Cell Structure

    Cell Structure

    MAHATHIR ALPHA · 82問 · 2年前

    Cell Structure

    Cell Structure

    82問 • 2年前
    MAHATHIR ALPHA

    Cell Histology

    Cell Histology

    MAHATHIR ALPHA · 91問 · 2年前

    Cell Histology

    Cell Histology

    91問 • 2年前
    MAHATHIR ALPHA

    Bacterial Growth

    Bacterial Growth

    MAHATHIR ALPHA · 46問 · 2年前

    Bacterial Growth

    Bacterial Growth

    46問 • 2年前
    MAHATHIR ALPHA

    Bacterial Genetics

    Bacterial Genetics

    MAHATHIR ALPHA · 29問 · 2年前

    Bacterial Genetics

    Bacterial Genetics

    29問 • 2年前
    MAHATHIR ALPHA

    Bacterial Metabolism

    Bacterial Metabolism

    MAHATHIR ALPHA · 23問 · 2年前

    Bacterial Metabolism

    Bacterial Metabolism

    23問 • 2年前
    MAHATHIR ALPHA

    First Module

    First Module

    MAHATHIR ALPHA · 67問 · 2年前

    First Module

    First Module

    67問 • 2年前
    MAHATHIR ALPHA

    Cellular Adaptation

    Cellular Adaptation

    MAHATHIR ALPHA · 64問 · 2年前

    Cellular Adaptation

    Cellular Adaptation

    64問 • 2年前
    MAHATHIR ALPHA

    Blood Collection

    Blood Collection

    MAHATHIR ALPHA · 21問 · 2年前

    Blood Collection

    Blood Collection

    21問 • 2年前
    MAHATHIR ALPHA

    Anticoagulants

    Anticoagulants

    MAHATHIR ALPHA · 43問 · 2年前

    Anticoagulants

    Anticoagulants

    43問 • 2年前
    MAHATHIR ALPHA

    Intro to Clinical Chemistry

    Intro to Clinical Chemistry

    MAHATHIR ALPHA · 71問 · 2年前

    Intro to Clinical Chemistry

    Intro to Clinical Chemistry

    71問 • 2年前
    MAHATHIR ALPHA

    Universal Precautions

    Universal Precautions

    MAHATHIR ALPHA · 37問 · 2年前

    Universal Precautions

    Universal Precautions

    37問 • 2年前
    MAHATHIR ALPHA

    Instrumentation

    Instrumentation

    MAHATHIR ALPHA · 32問 · 2年前

    Instrumentation

    Instrumentation

    32問 • 2年前
    MAHATHIR ALPHA

    Specimen Collection and Processing

    Specimen Collection and Processing

    MAHATHIR ALPHA · 43問 · 2年前

    Specimen Collection and Processing

    Specimen Collection and Processing

    43問 • 2年前
    MAHATHIR ALPHA

    Pathogenesis Part 1

    Pathogenesis Part 1

    MAHATHIR ALPHA · 78問 · 2年前

    Pathogenesis Part 1

    Pathogenesis Part 1

    78問 • 2年前
    MAHATHIR ALPHA

    Pathogenesis Part 2

    Pathogenesis Part 2

    MAHATHIR ALPHA · 72問 · 2年前

    Pathogenesis Part 2

    Pathogenesis Part 2

    72問 • 2年前
    MAHATHIR ALPHA

    Pregnancy test

    Pregnancy test

    MAHATHIR ALPHA · 94問 · 2年前

    Pregnancy test

    Pregnancy test

    94問 • 2年前
    MAHATHIR ALPHA

    The Control of Microbial Growth Part 1

    The Control of Microbial Growth Part 1

    MAHATHIR ALPHA · 62問 · 2年前

    The Control of Microbial Growth Part 1

    The Control of Microbial Growth Part 1

    62問 • 2年前
    MAHATHIR ALPHA

    The Control of Microbial Growth Part 2

    The Control of Microbial Growth Part 2

    MAHATHIR ALPHA · 58問 · 2年前

    The Control of Microbial Growth Part 2

    The Control of Microbial Growth Part 2

    58問 • 2年前
    MAHATHIR ALPHA

    Carbohydrates Part 1

    Carbohydrates Part 1

    MAHATHIR ALPHA · 76問 · 2年前

    Carbohydrates Part 1

    Carbohydrates Part 1

    76問 • 2年前
    MAHATHIR ALPHA

    Carbohydrate Part 2

    Carbohydrate Part 2

    MAHATHIR ALPHA · 86問 · 2年前

    Carbohydrate Part 2

    Carbohydrate Part 2

    86問 • 2年前
    MAHATHIR ALPHA

    Erythropoiesis

    Erythropoiesis

    MAHATHIR ALPHA · 70問 · 2年前

    Erythropoiesis

    Erythropoiesis

    70問 • 2年前
    MAHATHIR ALPHA

    Hemoglobin

    Hemoglobin

    MAHATHIR ALPHA · 49問 · 2年前

    Hemoglobin

    Hemoglobin

    49問 • 2年前
    MAHATHIR ALPHA

    Renal Disease

    Renal Disease

    MAHATHIR ALPHA · 54問 · 2年前

    Renal Disease

    Renal Disease

    54問 • 2年前
    MAHATHIR ALPHA

    Anemia

    Anemia

    MAHATHIR ALPHA · 72問 · 2年前

    Anemia

    Anemia

    72問 • 2年前
    MAHATHIR ALPHA

    RBC Anomalies

    RBC Anomalies

    MAHATHIR ALPHA · 40問 · 2年前

    RBC Anomalies

    RBC Anomalies

    40問 • 2年前
    MAHATHIR ALPHA

    Erythrocyte Disorders and Inclusions

    Erythrocyte Disorders and Inclusions

    MAHATHIR ALPHA · 32問 · 2年前

    Erythrocyte Disorders and Inclusions

    Erythrocyte Disorders and Inclusions

    32問 • 2年前
    MAHATHIR ALPHA

    RBC Abnormalities and Commoly Associated Disease Stain

    RBC Abnormalities and Commoly Associated Disease Stain

    MAHATHIR ALPHA · 32問 · 2年前

    RBC Abnormalities and Commoly Associated Disease Stain

    RBC Abnormalities and Commoly Associated Disease Stain

    32問 • 2年前
    MAHATHIR ALPHA

    Common Clinically Significant Hemoglobinopathies

    Common Clinically Significant Hemoglobinopathies

    MAHATHIR ALPHA · 63問 · 2年前

    Common Clinically Significant Hemoglobinopathies

    Common Clinically Significant Hemoglobinopathies

    63問 • 2年前
    MAHATHIR ALPHA

    Quality Control

    Quality Control

    MAHATHIR ALPHA · 49問 · 2年前

    Quality Control

    Quality Control

    49問 • 2年前
    MAHATHIR ALPHA

    Microscopy

    Microscopy

    MAHATHIR ALPHA · 33問 · 2年前

    Microscopy

    Microscopy

    33問 • 2年前
    MAHATHIR ALPHA

    Culture Media

    Culture Media

    MAHATHIR ALPHA · 40問 · 2年前

    Culture Media

    Culture Media

    40問 • 2年前
    MAHATHIR ALPHA

    Antimicrobial (Antibiotics)

    Antimicrobial (Antibiotics)

    MAHATHIR ALPHA · 66問 · 2年前

    Antimicrobial (Antibiotics)

    Antimicrobial (Antibiotics)

    66問 • 2年前
    MAHATHIR ALPHA

    Antibiotic Resistance

    Antibiotic Resistance

    MAHATHIR ALPHA · 19問 · 2年前

    Antibiotic Resistance

    Antibiotic Resistance

    19問 • 2年前
    MAHATHIR ALPHA

    Specimen collection, transport and processing

    Specimen collection, transport and processing

    MAHATHIR ALPHA · 19問 · 2年前

    Specimen collection, transport and processing

    Specimen collection, transport and processing

    19問 • 2年前
    MAHATHIR ALPHA

    Microscope specimens identification

    Microscope specimens identification

    MAHATHIR ALPHA · 25問 · 2年前

    Microscope specimens identification

    Microscope specimens identification

    25問 • 2年前
    MAHATHIR ALPHA

    Possible Identification Questions

    Possible Identification Questions

    MAHATHIR ALPHA · 28問 · 2年前

    Possible Identification Questions

    Possible Identification Questions

    28問 • 2年前
    MAHATHIR ALPHA

    Exam

    Exam

    MAHATHIR ALPHA · 24問 · 2年前

    Exam

    Exam

    24問 • 2年前
    MAHATHIR ALPHA

    Histopathology Midterm

    Histopathology Midterm

    MAHATHIR ALPHA · 35問 · 2年前

    Histopathology Midterm

    Histopathology Midterm

    35問 • 2年前
    MAHATHIR ALPHA

    Staphylococcus Part 1

    Staphylococcus Part 1

    MAHATHIR ALPHA · 80問 · 2年前

    Staphylococcus Part 1

    Staphylococcus Part 1

    80問 • 2年前
    MAHATHIR ALPHA

    Staphylococcus Part 2

    Staphylococcus Part 2

    MAHATHIR ALPHA · 79問 · 2年前

    Staphylococcus Part 2

    Staphylococcus Part 2

    79問 • 2年前
    MAHATHIR ALPHA

    WBC Anomalies

    WBC Anomalies

    MAHATHIR ALPHA · 67問 · 2年前

    WBC Anomalies

    WBC Anomalies

    67問 • 2年前
    MAHATHIR ALPHA

    WBC Anomaly Part II

    WBC Anomaly Part II

    MAHATHIR ALPHA · 67問 · 2年前

    WBC Anomaly Part II

    WBC Anomaly Part II

    67問 • 2年前
    MAHATHIR ALPHA

    Shortened ver. WBC

    Shortened ver. WBC

    MAHATHIR ALPHA · 68問 · 2年前

    Shortened ver. WBC

    Shortened ver. WBC

    68問 • 2年前
    MAHATHIR ALPHA

    Streptococcus Part 1

    Streptococcus Part 1

    MAHATHIR ALPHA · 81問 · 2年前

    Streptococcus Part 1

    Streptococcus Part 1

    81問 • 2年前
    MAHATHIR ALPHA

    Streptococcus Part 2

    Streptococcus Part 2

    MAHATHIR ALPHA · 81問 · 2年前

    Streptococcus Part 2

    Streptococcus Part 2

    81問 • 2年前
    MAHATHIR ALPHA

    Neisseria Part 1

    Neisseria Part 1

    MAHATHIR ALPHA · 59問 · 2年前

    Neisseria Part 1

    Neisseria Part 1

    59問 • 2年前
    MAHATHIR ALPHA

    Neisseria Part 2

    Neisseria Part 2

    MAHATHIR ALPHA · 56問 · 2年前

    Neisseria Part 2

    Neisseria Part 2

    56問 • 2年前
    MAHATHIR ALPHA

    Seminalysis Part 1

    Seminalysis Part 1

    MAHATHIR ALPHA · 58問 · 2年前

    Seminalysis Part 1

    Seminalysis Part 1

    58問 • 2年前
    MAHATHIR ALPHA

    Seminalysis Part 2

    Seminalysis Part 2

    MAHATHIR ALPHA · 63問 · 2年前

    Seminalysis Part 2

    Seminalysis Part 2

    63問 • 2年前
    MAHATHIR ALPHA

    CC quiz PROTEIN

    CC quiz PROTEIN

    MAHATHIR ALPHA · 15問 · 2年前

    CC quiz PROTEIN

    CC quiz PROTEIN

    15問 • 2年前
    MAHATHIR ALPHA

    AUBF QUIZ SEMINALYSIS

    AUBF QUIZ SEMINALYSIS

    MAHATHIR ALPHA · 10問 · 2年前

    AUBF QUIZ SEMINALYSIS

    AUBF QUIZ SEMINALYSIS

    10問 • 2年前
    MAHATHIR ALPHA

    Introduction to Leukemia Part 1

    Introduction to Leukemia Part 1

    MAHATHIR ALPHA · 67問 · 2年前

    Introduction to Leukemia Part 1

    Introduction to Leukemia Part 1

    67問 • 2年前
    MAHATHIR ALPHA

    Gastric Analysis

    Gastric Analysis

    MAHATHIR ALPHA · 73問 · 2年前

    Gastric Analysis

    Gastric Analysis

    73問 • 2年前
    MAHATHIR ALPHA

    Impregnation and Imbedding

    Impregnation and Imbedding

    MAHATHIR ALPHA · 50問 · 2年前

    Impregnation and Imbedding

    Impregnation and Imbedding

    50問 • 2年前
    MAHATHIR ALPHA

    Dehydration

    Dehydration

    MAHATHIR ALPHA · 34問 · 2年前

    Dehydration

    Dehydration

    34問 • 2年前
    MAHATHIR ALPHA

    Microtomy

    Microtomy

    MAHATHIR ALPHA · 49問 · 2年前

    Microtomy

    Microtomy

    49問 • 2年前
    MAHATHIR ALPHA

    Clearing

    Clearing

    MAHATHIR ALPHA · 32問 · 2年前

    Clearing

    Clearing

    32問 • 2年前
    MAHATHIR ALPHA

    Enterobacteriaceae Part 1

    Enterobacteriaceae Part 1

    MAHATHIR ALPHA · 91問 · 2年前

    Enterobacteriaceae Part 1

    Enterobacteriaceae Part 1

    91問 • 2年前
    MAHATHIR ALPHA

    Enterobacteriacea Part 2

    Enterobacteriacea Part 2

    MAHATHIR ALPHA · 24問 · 2年前

    Enterobacteriacea Part 2

    Enterobacteriacea Part 2

    24問 • 2年前
    MAHATHIR ALPHA

    Protein

    Protein

    MAHATHIR ALPHA · 83問 · 2年前

    Protein

    Protein

    83問 • 2年前
    MAHATHIR ALPHA

    Non Protein

    Non Protein

    MAHATHIR ALPHA · 39問 · 2年前

    Non Protein

    Non Protein

    39問 • 2年前
    MAHATHIR ALPHA

    Non-enteric gastrointesinal Pathogens

    Non-enteric gastrointesinal Pathogens

    MAHATHIR ALPHA · 72問 · 2年前

    Non-enteric gastrointesinal Pathogens

    Non-enteric gastrointesinal Pathogens

    72問 • 2年前
    MAHATHIR ALPHA

    Non-Fermentative Gram-Negative Bacilli

    Non-Fermentative Gram-Negative Bacilli

    MAHATHIR ALPHA · 92問 · 2年前

    Non-Fermentative Gram-Negative Bacilli

    Non-Fermentative Gram-Negative Bacilli

    92問 • 2年前
    MAHATHIR ALPHA

    Small, Pleomorphic Gram-negative bacilli Part 1

    Small, Pleomorphic Gram-negative bacilli Part 1

    MAHATHIR ALPHA · 100問 · 2年前

    Small, Pleomorphic Gram-negative bacilli Part 1

    Small, Pleomorphic Gram-negative bacilli Part 1

    100問 • 2年前
    MAHATHIR ALPHA

    Small, Pleomorphic Gram-negative bacilli Part 2

    Small, Pleomorphic Gram-negative bacilli Part 2

    MAHATHIR ALPHA · 86問 · 2年前

    Small, Pleomorphic Gram-negative bacilli Part 2

    Small, Pleomorphic Gram-negative bacilli Part 2

    86問 • 2年前
    MAHATHIR ALPHA

    Mycobacteria Part 1

    Mycobacteria Part 1

    MAHATHIR ALPHA · 100問 · 2年前

    Mycobacteria Part 1

    Mycobacteria Part 1

    100問 • 2年前
    MAHATHIR ALPHA

    Mycobacteria Part 2

    Mycobacteria Part 2

    MAHATHIR ALPHA · 100問 · 2年前

    Mycobacteria Part 2

    Mycobacteria Part 2

    100問 • 2年前
    MAHATHIR ALPHA

    Possible quiz questions amniotic

    Possible quiz questions amniotic

    MAHATHIR ALPHA · 24問 · 2年前

    Possible quiz questions amniotic

    Possible quiz questions amniotic

    24問 • 2年前
    MAHATHIR ALPHA

    Mycobacteria Part 3

    Mycobacteria Part 3

    MAHATHIR ALPHA · 95問 · 2年前

    Mycobacteria Part 3

    Mycobacteria Part 3

    95問 • 2年前
    MAHATHIR ALPHA

    Platelets

    Platelets

    MAHATHIR ALPHA · 100問 · 2年前

    Platelets

    Platelets

    100問 • 2年前
    MAHATHIR ALPHA

    Platelet Part II

    Platelet Part II

    MAHATHIR ALPHA · 30問 · 2年前

    Platelet Part II

    Platelet Part II

    30問 • 2年前
    MAHATHIR ALPHA

    Anaerobes Part 1

    Anaerobes Part 1

    MAHATHIR ALPHA · 100問 · 2年前

    Anaerobes Part 1

    Anaerobes Part 1

    100問 • 2年前
    MAHATHIR ALPHA

    Anaerobes Part 2

    Anaerobes Part 2

    MAHATHIR ALPHA · 83問 · 2年前

    Anaerobes Part 2

    Anaerobes Part 2

    83問 • 2年前
    MAHATHIR ALPHA

    Cell Wall-deficient Bacteria

    Cell Wall-deficient Bacteria

    MAHATHIR ALPHA · 41問 · 2年前

    Cell Wall-deficient Bacteria

    Cell Wall-deficient Bacteria

    41問 • 2年前
    MAHATHIR ALPHA

    Platelets Part 3 (Bookbased)

    Platelets Part 3 (Bookbased)

    MAHATHIR ALPHA · 56問 · 2年前

    Platelets Part 3 (Bookbased)

    Platelets Part 3 (Bookbased)

    56問 • 2年前
    MAHATHIR ALPHA

    Mounting Media and Adhesives

    Mounting Media and Adhesives

    MAHATHIR ALPHA · 56問 · 2年前

    Mounting Media and Adhesives

    Mounting Media and Adhesives

    56問 • 2年前
    MAHATHIR ALPHA

    問題一覧

  • 1

    - Acute megakaryoblastic leukemia - This is a rare disorder characterized by extensive proliferation of megakaryoblasts, atypical megakaryocytes and thrombocytopenia

    M7

  • 2

    What are the 2 goals in the treatment if Leukemias

    Eradicate the leukemic cell mass, Give supportive care

  • 3

    What are the four general types of theraphy for leukemias?

    Chemotherapy, Bone marrow transplant, Radiotheraphy, Immunotheraphy, Monoclonal antibodies

  • 4

    A combination of drugs is usually used in this theraphy

    Chemotheraphy

  • 5

    It stimulate the patients own immune system to mount a response against the malignant cells

    Immunotheraphy

  • 6

    An example of these are Rituxin

    Monoclonal antibodies

  • 7

    Fill in the Blanks: Blast cut-off for a diagnosis of AML WHO- ____ FAB- ____

    20%, 30%

  • 8

    AML with blasts 20 - 30 % by WHO can benefit from therapies for ________________ that were approved by USFDA

    MYELODYSPASIA

  • 9

    Small, monomorphic

    L1

  • 10

    Large, heterogenous

    L2

  • 11

    Burkitt-cell type

    L3

  • 12

    Minimally differentiated

    M0

  • 13

    Without maturation

    M1

  • 14

    With maturation

    M2

  • 15

    Hypergranular promyelocytic

    M3

  • 16

    Myelomonocytic

    M4

  • 17

    (a) monoblastic, (b) monocytic

    M5

  • 18

    Erythroleukemia

    M6

  • 19

    Megakaryoblastic

    M7

  • 20

    Undifferentiated blasts, AML-not otherwise categorized

    M0 myeloid

  • 21

    Blasts and promyelocytes predominate without further maturation of myeloid cells

    M1 myeloid

  • 22

    Myeloid cells demonstrate maturation beyond the blast and promyelocyte stage

    M2 myeloid

  • 23

    Promyelocytes predominate in the bone marrow

    M3 myelomonocyte

  • 24

    Both myeloid and monocytic cells are present to the extent of at least 20% of the total leukocytes

    M4 myelomonoctyic

  • 25

    Most cells are monocytic; two subtypes (a and b) are recognized, one characterized by large blasts in bone marrow and peripheral blood, the other (differentiated type) by monoblasts, promonocytes, and monocytes

    M5 monocytic

  • 26

    Also known as Di Guglielmo syndrome; abnormal proliferation of both erythroid and granulocytic precursors; may include abnormal megakaryocytic and monocytic proliferations

    M6 erythroleukemia

  • 27

    Large and small megakaryoblasts with a high nuclear- cytoplasmic ratio; pale, agranular cytoplasm

    M7 megakaryocytic

  • 28

    One population of cells within the case; small cells predominant; nuclear shape is regular with an occasional cleft; chromatin pattern is homogeneous and nucleoli are rarely visible; cytoplasm is moderately basophilic

    L1 homogenous

  • 29

    Large cells with an irregular nuclear shape; clefts in the nucleus are common; one or more large nucleoli are visible; cytoplasm varies in color

    L2 heterogenous

  • 30

    Cells are large and homogeneous in size; nuclear shape is round or oval; one to three prominent nucleoli; cytoplasm is deeply basophilic with vacuoles often prominent

    L3 Burkitt lymphoma type

  • 31

    Try to familliarize!

    .

  • 32

    Try to familliarize!

    .

  • 33

    Try to familliarize!

    .

  • 34

    Try to familliarize!

    .

  • 35

    Try to familliarize!

    .

  • 36

    Try to familliarize!

    .

  • 37

    There is an increase in both erythroblasts and myeloblasts

    Erythroleukemia

  • 38

    They may possibly cause myeloblastic leukemia

    M1, M2 or M4

  • 39

    3 sequentially morphological defined phases

    Preponderance of abnormal erythroblasts, Erythroleukemia, Myeloblastic leukemia

  • 40

    Erythroleukemia

    M6

  • 41

    -This is rare and is characterized by a bone marrow having a predominance of erythroblast -It has three sequentially morphologically defined phases -Anemia is common

    M6

  • 42

    -Acute monoblastic leukemia - >80% of the nonerythroid cells in the bone marrow are monocytic -There is extensive infiltration of the gums, CNS, lymph nodes and extramedullary sites

    M5

  • 43

    This type of M5 is well differentiated (<80% monoblasts)

    M5B

  • 44

    This type of M5 is poorly differentiated (>80% monoblasts)

    M5A

  • 45

    M5 is further divided into:

    M5A, M5B

  • 46

    -Acute myelomonoblastic leukemia -Both myeloblasts and monoblasts are seen in the bone marrow and peripheral blood -Infiltration of extramedullary sites is more common than with the pure granulocytic variants

    M4

  • 47

    -Hypogranular promyelocytic -The bone marrow has > 30% blasts -The WBC count is increased. -Like the M3 type, treatment causes a release of the granules and may send the patient into disseminated intravascular coagulation and subsequent bleeding and -It is characterized by a 15,17 translocation

    M3m

  • 48

    M3m is characterized by what?

    15,17 chromosomal translocation

  • 49

    M3 is characterized by what?

    15,17 chromosomal translocation

  • 50

    M2 is characterized by what?

    8,21 chromosomal translocation

  • 51

    What does the treatment of M3 causes?

    Treatment causes a release of the granules and may send the patient into disseminated intravascular coagulation and subsequent bleeding

  • 52

    -Hypergranular promyelocytic -This form of AML has a bone marrow with >30% blasts -Is more virulent than other forms -Occurs with a medium age of 39 -The WBC count is decreased -Treatment causes a release of the granules and may send the patient into disseminated intravascular coagulation and subsequent bleeding -It is characterized by a 15,17 chromosomal translocation

    M3

  • 53

    -Myeloblastic with maturation -The bone marrow shows 30-89% blasts and > 10% promyelocytes; -This is characterized by an 8,21 chromosomal translocation -This occurs in older adults

    M2

  • 54

    - Myeloblastic without maturation - The bone marrow shows >90% blasts and < 10% promyelocytes -The disease occurs in older adults

    M1

  • 55

    What are the different classifications of Acute myeloid leukemia ?

    M1, M2, M3, M3m, M4, M5, M6, M7

  • 56

    The classification of Acute myeloid leukemia depends on this factors

    Bone marrow blast morphology, Degree of cell maturation, Cytochemical stains, Immunophenotyping

  • 57

    What is the other term for Acute myeloid leukemia?

    Acute granulocyte leukemia

  • 58

    It is a rare trilineage leukemia

    B/T lymphoid/myeloid

  • 59

    Acute leukemias with mixed lineage(binotypic/phenotypes for two different lineages)

    B lymphoid/myeloid, T lymphoid/myeloid, B/T lymphoid, Myeloid/Natural killer, B/T lymphoid/myeloid

  • 60

    •It is more common in males •It has a poorer prognosis than any of the B cell ALLs which have a cure rate of 70%

    T cell ALL

  • 61

    True/False: If the WBC count is < 10 x 109/L at presentation, the prognosis is good; If the WBC count is > 20 x 109/L at presentation the prognosis is poor.

    True

  • 62

    Patients younger then 1 and greater than 13 have a _______________.

    poor prognosis

  • 63

    What are the most important prognostic indicators?

    Age, WBC counts, Cell type

  • 64

    Clinical findings of ALL

    Pancytopenia with resulting fatigue, pallor, fever, weight loss, irritability, anorexia, infection, bleeding, and bone pain.

  • 65

    Where does L2 occurs?

    In adults

  • 66

    Absence of any leukemia related signs and symptoms and return of bone marrow and peripheral blood values to within normal value

    Complete remission

  • 67

    Infiltration of extramedullary sites are common

    M4

  • 68

    Extensive infiltration of the gums, CNS....

    M5